Drugs that increase Dopamine Activity ( L-dopa and dopamine agonists)
Drugs that decrease Anti-cholinergic Activity (Anti cholinergic)
It serves as a mettafinoid Potentiator of Dopamine by increasing its release and synthesis and blocking its reuptake. It further acts as an adenosine A2 Antagonist as well as an NMDA Antagonist.
MAO-B Inhibitors work to increase extracellular Dopamine levels in the striatum by suppressing metabolism
COMT-Inhibitors work to inhibit COMT in the periphery thus decreasing peripheral metabolism as it inhibits the formation of 3-OMD.
Ergot derivative: Bromocriptine
Non-ergot derivative: Pramipexole and Ropinirole
Bromocriptine and Ropinirole: D2 Agonist
Pramipexole: D3 Agonist
Drugs such as Rasagiline are seen as neuroprotective as they prevent the degeneration of dopamine neurons due to constant stimulation
These drugs allow for Dopamine neurons to be constantly stimulated without allowing for degeneration as they are neuroprotective.
These drugs extend the action of L-dopa by decreasing the peripheral metabolism and increasing the bioavailability of dopamine and inhibiting the formation of the 3-OMD metabolite.
It functions as an adenosine A2A Antagonist by blocking the adenosine receptor, improve D2 function & also acts as an antiviral
It increases the activity of dopamine as it is a potent reversible MAO-B inhibitor an inhibits dopamine re-uptake .It also decreases glutamate release.